Roland E. Kontermann

11.8k citations
184 papers · 9.1k · 5 hit papers · h-index 47

Impact in

Papers in

Roland E. Kontermann

182 papers receiving 8.8k citations

Roland E. Kontermann's Hit Papers

The present and future of bispecific antibodies for cancer therapy 2024 · 241 citations
2410+10+21Years since publication250500750

Peers

Roland E. Kontermann
Comparison fields: 5 of 147
  • Radiology, Nuclear Medicine and Imaging 4.4k
  • Immunology 2.4k
  • Oncology 2.4k
  • Molecular Biology 4.9k
  • Biotechnology 388
Replace Nick Devoogdt with:
Nick Devoogdt Belgium
Christoph Rader United States
Mark I. Greene United States
Alfred L.M. Bothwell United States
Alan F. Wahl United States
Gerhard Moldenhauer Germany
Peter J. Hudson Australia
H. Michael Shepard United States
Stephen D. Gillies United States
Silvana Canevari Italy
Roland E. Kontermann relative to Nick Devoogdt Belgium Nick Devoogdt's profile →
Citations per field
00.5×1.6×
Nick Devoogdt · 1×
Citations per year

Countries citing papers authored by Roland E. Kontermann

Since Specialization
Citations

This map shows the geographic impact of Roland E. Kontermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland E. Kontermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland E. Kontermann more than expected).

Fields of papers citing papers by Roland E. Kontermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland E. Kontermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland E. Kontermann. The network helps show where Roland E. Kontermann may publish in the future.

Co-authors

The 25 scholars most cited alongside Roland E. Kontermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roland E. Kontermann Line = papers co-authored together Roland E. Kontermann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 184 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Isolation of high affinity human antibodies directly from large synthetic repertoires.
Hit paper breakdown →
1994818
2
The making of bispecific antibodies
Hit paper breakdown →
2017713
3
Bispecific antibodies
Hit paper breakdown →
2015469
4
Strategies for extended serum half-life of protein therapeutics
Hit paper breakdown →
2011454
5 2012349
6
The present and future of bispecific antibodies for cancer therapy
Hit paper breakdown →
2024241
7 2009182
8 2007172
9 2020172
10 2016159
11 2016126
12 2010117
13 2020116
14 2005108
15 1999106
16 2010101
17 200498
18 202196
19 201396
20 200194

About Roland E. Kontermann

Roland E. Kontermann is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Oncology and Genetics, having authored 184 papers that have together received 9.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (93 papers), Glycosylation and Glycoproteins Research (47 papers), CAR-T cell therapy research (23 papers), Protein purification and stability (19 papers), Immunotherapy and Immune Responses (17 papers), RNA Interference and Gene Delivery (16 papers), Peptidase Inhibition and Analysis (14 papers) and Cell death mechanisms and regulation (14 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (4.4k citations), Immunology (2.4k citations), Oncology (2.4k citations), Molecular Biology (4.9k citations) and Biotechnology (388 citations). Roland E. Kontermann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Ulrich Brinkmann, Dafne Müller, Klaus Pfizenmaier, Roman Fischer, Rolf Müller, Oliver Seifert, Oliver Hartley, Andrew D. Griffiths, Roland Stork and Peter M. Waterhouse. Their work appears in journals such as mAbs, Protein Engineering Design and Selection, Molecular Cancer Therapeutics, Journal of Immunotherapy and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact